Sort
15,842 grants matching “pancreatic cancer”
Chemical tools for developmental biology
$625,036James K Chen · Stanford University · R35 · FY2024 · GM
RAIT of Pancreatic Cancer with Humanized PAM4
$624,927Ctr For Molecular Medicine/Immunology · R01 · FY2003 · CA
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy
$624,558Eric Collisson · University Of California, San Francisco · R01 · FY2021 · CA
Optimizing Ultrasound Enhanced Delivery of Therapeutics
$624,449Flemming Forsberg · Thomas Jefferson University · R01 · FY2017 · CA
Designing a Plan of Action for Better Access and Quality of Surgery for African-Americans with Gastrointestinal Cancers in the Deep South
$624,429Maria Pisu · University Of Alabama At Birmingham · R01 · FY2021 · MD
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods
$624,279Ben Z Stanger · University Of Pennsylvania · R01 · FY2024 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$623,803Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$623,803Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$623,803Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$623,618John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers
$623,533Brian B Haab · Van Andel Research Institute · U01 · FY2016 · CA
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
$623,472Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
$623,472Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Immunobiology and immunotherapy of pancreatic cancer
$623,108Robert H Vonderheide · University Of Pennsylvania · R01 · FY2012 · CA
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
$623,084Vinod P Balachandran · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
In Vivo Base Editing for Precision Oncology Models
$623,053Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Systems Metabolic Approach for Multi-scale Pancreatic Cancer Phenotyping
$622,984Neema Jamshidi · University Of California Los Angeles · R37 · FY2024 · CA
Genetic Epidemiology of Melanoma
$622,906David E E Elder · University Of Pennsylvania · R01 · FY2010 · CA
CCR FACS Core Laboratory
$622,887Barbara Taylor · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Endoscopic Fine-Needle Light Scattering Spectroscopy for Pancreatic Cyst Diagnosis and Evaluation of Malignant Potential
$622,771Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2025 · EB
Peripheral Nerve Regulation of Pancreas Cancer Progression
$622,548Jami Lynn Saloman · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Peripheral Nerve Regulation of Pancreas Cancer Progression
$622,548Jami Lynn Saloman · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
$622,418Anna E Lokshin · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Genome-wide Copy Number Variation and Breast Cancer Risk
$622,281Jirong Long · Vanderbilt University · R01 · FY2010 · CA
A multimodal imaging system and targeted nanoprobes for image-guided treatment of breast cancer
$622,134Huabei Jiang · University Of South Florida · R01 · FY2018 · EB